Millions of Americans take fish oil supplements in hopes of protecting their memory and keeping their brains healthy as they age. These products have become a major business, with Americans spending more than $1 billion each year on supplements containing omega-3 fatty acids. These essential nutrients help build and maintain the connections between brain cells that support memory, learning, and other cognitive functions.
But a new study suggests that getting more omega-3s into the brain through supplements may not provide the protection many people expect.
Researchers at Keck Medicine of USC found that even when high doses of omega-3s successfully reached the brain, they did not produce measurable improvements in memory, thinking abilities, or protection against brain shrinkage.
The findings, published in eBioMedicine, come from a two-year clinical trial involving older adults considered to be at increased risk of developing Alzheimer’s disease. Despite taking omega-3 supplements daily, participants showed no significant cognitive advantage over those who received a placebo.
“We all wish there was a silver bullet for preventing Alzheimer’s, but our findings showed that fish oil supplements do not appear to protect brain health,” said Hussein Naji Yassine, MD, director of the USC Center for Personalized Brain Health and lead investigator of the study. “While omega-3s play an important role in forming brain cell connections needed for cognition, our results do not support fish oil supplements as a preventive measure against Alzheimer’s.”
A Two-Year Study Tests Fish Oil’s Brain Benefits
To investigate whether omega-3 supplements could protect the aging brain, researchers enrolled 365 adults between the ages of 55 and 80. All participants rarely ate fish, a major dietary source of omega-3 fatty acids, and were considered at elevated risk for Alzheimer’s disease.
Nearly half (47%) carried APOE4, a gene variant associated with a substantially higher risk of developing Alzheimer’s later in life. Although having this variant does not mean someone will necessarily develop the disease, it is the strongest known genetic risk factor for late-onset Alzheimer’s.
Participants were randomly assigned to receive either a daily fish oil supplement or a placebo, an inactive treatment used for comparison. The supplements provided 2,000 mg of docosahexaenoic acid (DHA), an omega-3 fatty acid that is especially important for the brain.
DHA is a major component of brain cell membranes, helping maintain the structure and function of neurons. It also supports communication between nerve cells, making it an important nutrient for normal brain activity.
The study was double-blind, meaning neither participants nor researchers knew who was receiving the active supplement during the trial. This approach helps reduce bias and makes it easier to determine whether any observed benefits are actually caused by the treatment.
Omega-3 Levels Rose, but Memory Did Not Improve
Before evaluating whether the supplements improved brain health, researchers needed to answer a fundamental question: Were the omega-3 fatty acids actually reaching the brain?
To find out, they measured DHA concentrations in cerebrospinal fluid, the clear liquid that surrounds and cushions the brain and spinal cord. Examining this fluid can provide information about substances entering and circulating within the central nervous system.
After six months, DHA levels in the cerebrospinal fluid had increased by an average of 17% among participants taking the supplements. This provided evidence that the omega-3 fatty acids were reaching their intended destination.
However, getting DHA into the central nervous system was only part of the goal. The more important question was whether those higher levels would translate into better brain health.
Researchers assessed participants’ memory and other cognitive abilities at the beginning of the trial and again after two years. Despite the increase in DHA, those taking fish oil performed no better on the cognitive tests than participants receiving the placebo.
Brain imaging revealed similarly disappointing results.
The supplements did not prevent shrinkage of the hippocampus, a region deep within the brain that plays a central role in forming and organizing memories. The hippocampus is particularly vulnerable to changes associated with aging and Alzheimer’s disease, making its size an important indicator researchers use when studying brain health.
Taken together, the results suggest that simply increasing DHA availability in the brain is not enough to produce measurable cognitive benefits in this group of older adults.
Why Fish Oil Supplements May Work Differently Than Food
The unexpected findings have raised a new question for researchers: If omega-3s can reach the brain, why don’t higher levels necessarily improve its function?
Yassine and his colleagues are now investigating how the brain absorbs, processes, and uses these nutrients. Their earlier research suggests that omega-3s may be more beneficial when consumed as part of a broader dietary pattern rather than taken in isolation as a supplement.
One possibility involves the Mediterranean-style diet, which emphasizes foods such as fish, vegetables, fruits, whole grains, legumes, nuts, and olive oil. This eating pattern naturally supplies omega-3 fatty acids alongside other nutrients and has been associated with a lower risk of Alzheimer’s disease.
The researchers suspect that the combination of nutrients in a balanced diet, along with an individual’s overall health, may influence how effectively omega-3s support the brain.
“We’re focused on better understanding how the brain processes omega-3s and whether factors, such as poor health, dietary pattern, genetic risk and age, may change the brain’s ability to effectively absorb and use omega-3s,” said Yassine. “We are working to develop medications that may help the brain better utilize these nutrients to preserve cognitive function.”
Understanding these differences could eventually help scientists identify why certain people might respond better to omega-3s than others and whether new treatments could improve the brain’s ability to benefit from these essential fats.
Importantly, the findings do not mean omega-3 fatty acids are unnecessary or that eating fish offers no health benefits. Instead, they indicate that taking high-dose DHA supplements alone did not provide measurable protection against cognitive decline or hippocampal shrinkage in the population studied.
Healthy Habits Remain Key to Alzheimer’s Prevention
Although the trial focused specifically on fish oil supplements, the researchers emphasize that protecting brain health requires a much broader approach.
Rather than relying on a single supplement, they recommend maintaining healthy habits throughout life, including regular physical activity, sufficient high-quality sleep, and a nutritious, balanced diet.
These behaviors support overall health and may help reduce factors associated with cognitive decline. Physical exercise, for example, promotes cardiovascular health and blood flow, while sleep plays an important role in memory formation and normal brain maintenance.
“Staying healthy throughout life remains the most powerful tool we have for reducing Alzheimer’s risk, including regular exercise, quality sleep and a balanced diet,” said Yassine. “Living a healthy lifestyle is the brain’s equivalent of getting regular car maintenance and high-quality oil changes. The brain is more likely to lose greater function if health issues in other parts of the body go unaddressed, in the same way that car engines stop working if regular maintenance is skipped.”
While these lifestyle factors were not directly tested in the trial, the researchers believe they offer a more promising foundation for long-term brain health than depending on fish oil supplements alone.
The results also highlight an important distinction: A nutrient can be essential for healthy brain function without providing additional protection when consumed in large doses as a supplement. Understanding why that happens may open new avenues for research into Alzheimer’s prevention and the nutritional needs of the aging brain.
The research was supported by the National Institutes of Health, grant numbers RF1AG076124, R01AG055770, R01AG067063, R01AG054434, R21AG056518, P30AG066530 and R01AG054434 and the Alzheimer’s Drug Discovery Foundation, grant number GC-201711-2014197.
